oxandrolone sold brand names oxandrin anavar among others androgen anabolic steroid aas medication used help promote weight gain various situations help offset protein catabolism caused longterm corticosteroid therapy support recovery severe burns treat bone pain associated osteoporosis aid development girls turner syndrome taken side effects oxandrolone include increased sexual desire symptoms hyperandrogenism acne symptoms masculinization increased hair growth voice drug synthetic androgen anabolic steroid hence agonist androgen receptor ar biological target androgens testosterone strong anabolic effects weak androgenic effects give mild side effect profile make especially suitable use oxandrolone first described introduced medical use drug controlled substance many countries nonmedical use purposes improving physique performance generally although primarily used united states fda announced june drug would longer approved medical use august neither brand generic versions oxandrolone legally marketed oxandrolone researched prescribed treatment wide variety conditions fdaapproved treating bone pain associated osteoporosis aiding weight gain following surgery physical trauma chronic infection context unexplained weight loss counteracting catabolic effect longterm corticosteroid often prescribed offlabel quicken recovery severe burns aid development girls turner syndrome counteract hivaidsinduced wasting oxandrolone improves shortterm longterm outcomes people recovering severe burns wellestablished safe treatment one underlying mechanisms burn management oxandrolone helps reduce hypermetabolic response characterized increased energy expenditure elevated stress hormones levels cortisol insulin resistance muscle wasting impaired wound healing response reduced improving wholebody nitrogen balance well preserving lean body mass oxandrolone also used treatment idiopathic short stature anemia hereditary angioedema alcoholic hepatitis medical research established effectiveness oxandrolone aiding development girls turner syndrome although oxandrolone long used accelerate growth children idiopathic short stature unlikely increase adult height cases may even decrease itcitation needed oxandrolone therefore largely replaced growth hormone however systematic review comparing effects adding oxandrolone growth hormone treatment growth hormone alone found moderatequality evidence addition oxandrolone leads increase final adult height girls turner syndrome lowquality evidence showed increase adverse review assessed effects adding oxandrolone growth hormone treatment speech cognition psychological status results inconclusive due verylow quality children idiopathic short stature turner syndrome given doses oxandrolone far smaller given people burns minimize likelihood virilization premature study found administration oxandrolone transgender adolescents resulted increase adult many bodybuilders athletes use oxandrolone illicitly musclebuilding much anabolic androgenic women seeking less intense steroid regimens use particularly many also value oxandrolones low hepatotoxicity relative orally active like aass oxandrolone may worsen hypercalcemia increasing osteolytic bone taken pregnant women oxandrolone may unintended effects masculinization women administered oxandrolone may experience virilization irreversible development masculine features voice deepening hirsutism menstruation abnormalities malepattern hair loss clitoral side effects doses given women children minimized people usually monitored virilization growth like androgens oxandrolone cause worsen acne priapism unwanted prolonged oxandrolone also reduce males fertility another side effect common among attempt compensate exogenous increase androgens body may reduce testosterone production via testicular atrophy inhibition gonadotropic unlike aass oxandrolone generally cause gynecomastia aromatized estrogenic however although reports gynecomastia made spite widespread use oxandrolone reported publication associated cases gynecomastia adolescent boys treated short gynecomastia developed oxandrolone therapy boys therapy completed boys boys transient gynecomastia persistent gynecomastia necessitated though transient gynecomastia natural common occurrence pubertal boys gynecomastia associated oxandrolone latedelayed onset persistent high percentage researchers stated although oxandrolone implicated stimulatory gynecomastia possible relationship considered clinicians using oxandrolone adolescents growth uniquely among aass oxandrolone shows little hepatotoxicity even high cases severe hepatotoxicity singularly attributed however elevated liver enzymes observed people particularly high doses andor prolonged treatment although return normal ranges following oxandrolone greatly increases warfarins bloodthinning effect sometimes dangerously april savient pharmaceuticals published safety alert fda warning healthcare professionals oxandrolone also inhibit metabolism oral hypoglycemic may worsen edema taken alongside corticosteroids adrenocorticotropic like aass oxandrolone agonist androgen receptor similar androgens testosterone relative binding affinity oxandrolone androgen receptor activation androgen receptor stimulates protein synthesis increases muscle growth lean body mass bone mineral compared testosterone many aass oxandrolone less androgenic relative strength oxandrolone anabolic potency androgenic potency similarly oxandrolone much times anabolic potency testosterone significantly reduced androgenic potency reduced ratio anabolic androgenic activity oxandrolone often motivates medical use children women less androgenic effect implies less risk bodybuilding community also considers fact choosing oxandrolone already substrate hence potentiated androgenic tissues skin hair follicles prostate involved reduced ratio anabolic androgenic due substitution one carbon atoms oxygen atom position ring oxandrolone resistant inactivation dehydrogenase skeletal contrast dht thought underlie preserved anabolic potency oxandrolone substrate aromatase hence aromatized metabolites estrogenic oxandrolone similarly possesses progestogenic oxandrolone uniquely far less hepatotoxic aass may due differences oral bioavailability oxandrolone plasma protein binding drug metabolized primarily kidneys lesser extent oxandrolone aas primarily extensively metabolized liver thought related diminished hepatotoxicity relative elimination halflife reported hours extended hours oral dose oxandrolone eliminated unchanged urine excreted oxandrolone synthetic androstane steroid derivative also known dht methyl group position carbon replaced oxygen closely related aass include marketed aas mestanolone oxymetholone stanozolol ringfused derivative nevermarketeddesigner aas desoxymethyltestosterone methasterone methylstenbolone oxandrolone first made raphael pappo christopher j jung searle laboratories part pfizer researchers first described drug immediately interested oxandrolones weak androgenic effects relative anabolic introduced pharmaceutical drug united states drug prescribed promote muscle regrowth disorders cause involuntary weight loss used part treatment also shown partially successful treating cases however part due bad publicity illicit use bodybuilders production anavar discontinued searle laboratories picked biotechnology general corporation changed name savient pharmaceuticals following successful clinical trials released brand name btg subsequently approvals orphan drug status food drug administration treating alcoholic hepatitis turner syndrome hivinduced weight also indicated offset protein catabolism caused longterm administration oxandrolone generic name drug inntooltip international nonproprietary name usantooltip united states adopted name usptooltip united states pharmacopeia bantooltip british approved name dcftooltip dénomination commune française dcittooltip denominazione comune italiana jantooltip japanese accepted name ossandrolone formerly dcittooltip denominazione comune original brand name oxandrolone anavar marketed united states product eventually discontinued replaced united states new product named oxandrin sole remaining brand name oxandrolone united oxandrolone also sold brand names antitriol spain anatrophill france lipidex brazil lonavar argentina australia italy protivar vasorome japan among additional brand names exist products manufactured steroid black among using oxandrolone nonmedical purposes often referred colloquially var shortened form brand name oxandrolone one aass remains available medical use united others august testosterone testosterone cypionate testosterone enanthate testosterone undecanoate methyltestosterone fluoxymesterone june fda formally withdrew approval oxandrolone indications stating possible adverse effects drug sufficiently serious warrant removal us market august neither brand generic versions oxandrolone outside united states availability oxandrolone quite exception moldova longer available oxandrolone available lessregulated markets asia also available historically oxandrolone marketed argentina australia brazil france italy japan spain appears longer available united states oxandrolone categorized schedule iii controlled substance controlled substances act along many schedule iv controlled substance schedule controlled drug united oxandrolone sometimes used doping agent sports cases doping oxandrolone professional athletes reportedcitation needed httpsenwikipediaorgwikioxandrolone